Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Validation of a Non-invasive In-vitro Diagnostic Test (Peptest) Against Other Diagnostic Methods for GERD
A completed clinical trial evaluated Peptest, a non-invasive in vitro diagnostic, against other diagnostic methods for Gastroesophageal refl…
-
FDA approval · 2017-11-30FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
The FDA approved a supplemental application for Equate Lansoprazole, Wal-Mart's store-brand lansoprazole.
-
CLINICAL_TRIALS research · 2017-11-22Clinical Trial Update: Study of Gastro-oesophageal Reflux in Patients Having Had Bariatric Surgery
A clinical trial evaluating gastroesophageal reflux in patients who have had bariatric surgery has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects [Phase 1]
This is a Phase 1 study evaluating pharmacokinetics, pharmacodynamics, and safety of CKD-381 in healthy subjects. The trial status is comple…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Prevalence and Clinical Characteristics of Patients With Jackhammer Esophagus and Symptoms of Gastroesophageal Reflux Disease
This clinical trial update reports on the prevalence of jackhammer esophagus and outlines the clinical characteristics of patients with this…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-11-17Clinical Trial Update: In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms? [NA]
Clinical trial investigating acid-blocking medications for respiratory symptoms in infants with laryngomalacia has been withdrawn. The relat…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.
Completed clinical trial evaluating empirical proton pump inhibitor treatment for outpatients with typical gastroesophageal reflux disease s…
-
FDA approval · 2017-11-15FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
The FDA approved a supplemental application for Equate Lansoprazole (lansoprazole) filed by Wal-Mart Stores Inc. The action relates to this …
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: SWAN: Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01) [NA]
A completed clinical trial evaluating the tolerance and efficacy of PC-2016-01, an anti-regurgitation formula, for gastroesophageal reflux d…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Influence of Intrapulmonary Percussive Ventilation (IPV) on Gastro-oesophageal Reflux (GOR). [NA]
Completed clinical trial assessing the effect of intrapulmonary percussive ventilation on gastroesophageal reflux disease (GERD).
-
FDA approval · 2017-10-30FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole), with AmerisourceBergen as the manufacturer, …
-
FDA approval · 2017-10-30FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
The FDA approved a supplemental application for ZEGERID OTC (omeprazole with sodium bicarbonate) under Riley Consumer Care LLC, supporting i…
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Cardiaplication: A Novel Antireflux Operation [NA]
Clinical trial update indicates the Cardiaplication antireflux surgery study has completed for gastroesophageal reflux disease.
-
FDA approval · 2017-10-18FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Prevacid Solutab (lansoprazole) by Takeda Pharmaceuticals America, Inc., related to the Solu…
-
FDA approval · 2017-10-17FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Dexilant (dexlansoprazole) from Takeda Pharmaceuticals America, resulting in changes to the prod…
-
CLINICAL_TRIALS withdrawal · 2017-10-16Clinical Trial Update: RELIEF Europe Study [NA]
The RELIEF Europe Study, sponsored by Torax Medical, evaluating GERD and obesity-related conditions, has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients [Phase 3]
Phase 3 esophageal pH study of compound sodium alginate oral suspension in GERD has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-10-04Clinical Trial Update: Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease [Phase 4]
Phase 4 clinical trial update for dexlansoprazole in Asian patients with gastroesophageal reflux disease completed with results posted.
-
FDA approval · 2017-09-28FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole by Sandoz Inc (ANDA 076515).
-
FDA approval · 2017-09-21FDA Approved: LANSOPRAZOLE — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's original ANDA for lansoprazole, enabling a generic version to be marketed for acid-related disorders.
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan [Phase 4]
Phase 4 open-label trial evaluating dexlansoprazole 60 mg for relief of heartburn during Ramadan; completed.
-
FDA approval · 2017-08-30FDA Approved: LANSOPRAZOLE — Original Application (Lifestar Pharma LLC.)
FDA approves a generic lansoprazole under an Original Application (ANDA) for Lifestar Pharma LLC.
-
CLINICAL_TRIALS withdrawal · 2017-08-29Clinical Trial Update: Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy [Phase 4]
A Phase 4 placebo-controlled trial of baclofen for gastroesophageal reflux disease in children with cerebral palsy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity [Phase 4]
Phase 4 study evaluating the effect of dexrabeprazole on intragastric and intraesophageal acidity in gastroesophageal reflux disease. The tr…
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Effect of Right Lateral Position on Ventilated Preterm Neonates [NA]
A completed clinical trial evaluated the effect of a right lateral position on gastroesophageal reflux in ventilated preterm neonates.